search
Back to results

Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome

Primary Purpose

Overactive Bladder Syndrome

Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
TENS 1-1
TENS 1-2
TENS 2-1
TENS 2-2
TENS 0-1
Sponsored by
University of Sao Paulo General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Overactive Bladder Syndrome

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Women with 18 years of age or more;
  • Cognitive level adequate for understanding orientations during treatment;
  • Clinical diagnosis of overactive bladder syndrome for at least six months prior to the study.

Exclusion Criteria:

  • Pregnant women or women who wish to get pregnant;
  • Neurological disease;
  • Urinary infection;
  • Nephrolithiasis;
  • Stress urinary incontinence;
  • Mixed urinary incontinence;
  • Women in pharmacological treatment for overactive bladder syndrome;
  • Women undergoing hormone replacement therapy in the last six months;
  • Peripheral neuropathy;
  • Cystocele stage two or higher.

Sites / Locations

  • Gynecology Ambulatory of the General Hospital of the Faculty of Medicine of the University of Sao Paulo

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Placebo Comparator

Experimental

Experimental

Experimental

Experimental

Arm Label

Group TENS 0-1

Group TENS 1-1

Group TENS 1-2

Group TENS 2-1

Group TENS 2-2

Arm Description

Electrodes will be fixated to one leg and sessions will be held once a week.

Electrical stimulation of the posterior tibial nerve of one leg once a week.

Electrical stimulation of the posterior tibial nerve of one leg twice a week.

Electrical stimulation of the posterior tibial nerve of two legs once a week.

Electrical stimulation of the posterior tibial nerve of two legs twice a week.

Outcomes

Primary Outcome Measures

Change in urinary frequence in 12 sessions.
Number of micturitions per day.

Secondary Outcome Measures

Change in Nocturia in 12 sessions.
Number of micturitions per night, interrupting sleep.
Change in urinary urgence in 12 sessions.
Number of urgent micturitions per day.
Change in urinary urge-incontinence in 12 sessions.
Number of leaks per day.

Full Information

First Posted
June 5, 2013
Last Updated
February 12, 2019
Sponsor
University of Sao Paulo General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01912885
Brief Title
Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome
Official Title
Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome: Randomized Blind Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
October 9, 2013 (Actual)
Primary Completion Date
August 25, 2014 (Actual)
Study Completion Date
September 25, 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Sao Paulo General Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
INTRODUCTION: Overactive bladder syndrome is defined by The International Continence Society as urgency, with or without incontinence, usually with increased urinary frequency and nocturia. It is difficult to estimate the prevalence of this syndrome because many patients do not seek medical help, despite considerable negative impact on quality of life. Lower urinary tract dysfunctions can be treated using electrical stimulation of the posterior tibial nerve. This therapy is conservative, effective, inexpensive and promotes high adhesion to treatment. It has good results, decreasing symptoms of urgency, urge-incontinence, urinary frequency and nocturia . Due to lack of consensus on the parameters of this technique, further research is necessary. OBJECTIVE: To compare the effectiveness of protocols for the electrical stimulation of the posterior tibial nerve for treatment of non-neurogenic overactive bladder. METHODS: The study was a blind randomized clinical trial. The study will accept up to 145 women with overactive bladder diagnosis for at least six months prior to the beginning of the study. The subjects will be divided into five groups: group TENS 0-1 (placebo group), group TENS 1-1 (electrical stimulation of one leg once a week), group TENS 1-2 (electrical stimulation of one leg twice a week), group TENS 2-1 (electrical stimulation of two legs one a week) and group TENS 2-2 (electrical stimulation of two legs twice a week). Physical evaluation will be done at the beginning and at the end of the treatment. Evaluation will be done using the King "s Health Questionnaire, the International Consultation Incontinence Questionnaire - Short Form, the Overactive Bladder Questionnaire, a three day urinary diary and a table for follow-up treatment.
Detailed Description
Participants will be recruited from Urogynecology Physical Therapy Outpatient Clinic of a university hospital and randomly assigned using website www.randomization.com and distributed into five groups considering the sites of application and frequency of attendanc, listed above. Data will be collected by the investigator using interview and physical examination and will be safely stored in computer. For this study, in terms of urinary frequency, the standard deviation was estimated at 3.25 episodes of urinary urgency (SD=3.25). With 80% power and 95% confidence, the sample size calculation was 25 women in each group, plus a possible sample loss of around 20%, resulting in a sample size of 29 women per group, for a total of 145 patients in the study. The chi-square test was used to assess whether there was an association between sample description variables and treatments. The analysis of variance F-test was used to assess whether there were differences in the numerical descriptive variables between treatment groups. The nonparametric Kruskal-Wallis test was used to compare treatments in terms of the difference between before and after for each quality of life and voiding diary variables. If there was statistical significance, the Dunn multiple comparison test was performed, with p-values of less than 0.05 considered significant. The analysis of variance model with repeated measures was used to compare data from the specific voiding diary according to the treatment groups and sessions. Significant comparisons were evaluated with Tukey post-hoc test. To approximate data to the normality, a 1/log (variable+1) transformation was done. For the follow up analysis, it was used the ANOVA three ways, with Holm Sidak post-hoc test for comparison of scores. All the statistical tests developed were based on a significance of 5%, i.e., the null hypothesis was rejected when the p-value was less than 0.05.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overactive Bladder Syndrome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
145 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group TENS 0-1
Arm Type
Placebo Comparator
Arm Description
Electrodes will be fixated to one leg and sessions will be held once a week.
Arm Title
Group TENS 1-1
Arm Type
Experimental
Arm Description
Electrical stimulation of the posterior tibial nerve of one leg once a week.
Arm Title
Group TENS 1-2
Arm Type
Experimental
Arm Description
Electrical stimulation of the posterior tibial nerve of one leg twice a week.
Arm Title
Group TENS 2-1
Arm Type
Experimental
Arm Description
Electrical stimulation of the posterior tibial nerve of two legs once a week.
Arm Title
Group TENS 2-2
Arm Type
Experimental
Arm Description
Electrical stimulation of the posterior tibial nerve of two legs twice a week.
Intervention Type
Device
Intervention Name(s)
TENS 1-1
Intervention Description
Electrical stimulation using Transcutaneous Electrical Nerve Stimulation on one leg once a week.
Intervention Type
Device
Intervention Name(s)
TENS 1-2
Intervention Description
Electrical stimulation using Transcutaneous Electrical Nerve Stimulation on one leg twice a week.
Intervention Type
Device
Intervention Name(s)
TENS 2-1
Intervention Description
Electrical stimulation using Transcutaneous Electrical Nerve Stimulation on two legs once a week.
Intervention Type
Device
Intervention Name(s)
TENS 2-2
Intervention Description
Electrical stimulation using Transcutaneous Electrical Nerve Stimulation on two legs twice a week.
Intervention Type
Device
Intervention Name(s)
TENS 0-1
Intervention Description
Placebo: application os electrodes of Transcutaneous Electrical Nerve Stimulation on one leg once a week, without turning on the device.
Primary Outcome Measure Information:
Title
Change in urinary frequence in 12 sessions.
Description
Number of micturitions per day.
Time Frame
The patients fill in a bladder diary of 3 days running. One bladder diary starting in the first session and the last one to end in the last session.
Secondary Outcome Measure Information:
Title
Change in Nocturia in 12 sessions.
Description
Number of micturitions per night, interrupting sleep.
Time Frame
The patients fill in a bladder diary of 3 days running. One bladder diary starting in the first session and the last one to end in the last session.
Title
Change in urinary urgence in 12 sessions.
Description
Number of urgent micturitions per day.
Time Frame
The patients fill in a bladder diary of 3 days running. One bladder diary starting in the first session and the last one to end in the last session.
Title
Change in urinary urge-incontinence in 12 sessions.
Description
Number of leaks per day.
Time Frame
The patients fill in a bladder diary of 3 days running. One bladder diary starting in the first session and the last one to end in the last session.

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women with 18 years of age or more; Cognitive level adequate for understanding orientations during treatment; Clinical diagnosis of overactive bladder syndrome for at least six months prior to the study. Exclusion Criteria: Pregnant women or women who wish to get pregnant; Neurological disease; Urinary infection; Nephrolithiasis; Stress urinary incontinence; Mixed urinary incontinence; Women in pharmacological treatment for overactive bladder syndrome; Women undergoing hormone replacement therapy in the last six months; Peripheral neuropathy; Cystocele stage two or higher.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elizabeth AG Ferreira, PhD
Organizational Affiliation
Faculty of Medicine, University of São Paulo, São Paulo, Brazil
Official's Role
Study Director
Facility Information:
Facility Name
Gynecology Ambulatory of the General Hospital of the Faculty of Medicine of the University of Sao Paulo
City
Sao Paulo
ZIP/Postal Code
05403000
Country
Brazil

12. IPD Sharing Statement

Citations:
PubMed Identifier
34406271
Citation
Pierre ML, Friso B, Casarotto RA, Haddad JM, Baracat EC, Ferreira EAG. Comparison of transcutaneous electrical tibial nerve stimulation for the treatment of overactive bladder: a multi-arm randomized controlled trial with blinded assessment. Clinics (Sao Paulo). 2021 Aug 16;76:e3039. doi: 10.6061/clinics/2021/e3039. eCollection 2021.
Results Reference
derived

Learn more about this trial

Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome

We'll reach out to this number within 24 hrs